106 related articles for article (PubMed ID: 28414327)
1. A novel antibody against cancer stem cell biomarker, DCLK1-S, is potentially useful for assessing colon cancer risk after screening colonoscopy.
Sarkar S; Popov VL; O'Connell MR; Stevenson HL; Lee BS; Obeid RA; Luthra GK; Singh P
Lab Invest; 2017 Oct; 97(10):1245-1261. PubMed ID: 28414327
[TBL] [Abstract][Full Text] [Related]
2. Dominant Expression of DCLK1 in Human Pancreatic Cancer Stem Cells Accelerates Tumor Invasion and Metastasis.
Ito H; Tanaka S; Akiyama Y; Shimada S; Adikrisna R; Matsumura S; Aihara A; Mitsunori Y; Ban D; Ochiai T; Kudo A; Arii S; Yamaoka S; Tanabe M
PLoS One; 2016; 11(1):e0146564. PubMed ID: 26764906
[TBL] [Abstract][Full Text] [Related]
3. Chemical Biology Toolkit for DCLK1 Reveals Connection to RNA Processing.
Liu Y; Ferguson FM; Li L; Kuljanin M; Mills CE; Subramanian K; Harshbarger W; Gondi S; Wang J; Sorger PK; Mancias JD; Gray NS; Westover KD
Cell Chem Biol; 2020 Oct; 27(10):1229-1240.e4. PubMed ID: 32755567
[TBL] [Abstract][Full Text] [Related]
4. Design and synthesis of doublecortin-like kinase 1 inhibitors and their bioactivity evaluation.
Pan P; Ji D; Li Z; Meng X
J Enzyme Inhib Med Chem; 2024 Dec; 39(1):2287990. PubMed ID: 38062554
[TBL] [Abstract][Full Text] [Related]
5. Functional assessment of miR‑1291 in colon cancer cells.
Wang J; Yokoyama Y; Hirose H; Shimomura Y; Bonkobara S; Itakura H; Kouda S; Morimoto Y; Minami K; Takahashi H; Shibata S; Kobayashi S; Uemura M; Tanaka S; Wu X; Tanaka S; Mori M; Yamamoto H
Int J Oncol; 2022 Feb; 60(2):. PubMed ID: 34981812
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and biological evaluation of novel DCLK1 inhibitor containing purine skeleton for the treatment of pancreatic cancer.
Chen Y; Meng L; Wang W; Ye L; Huang L; Wang C; Wang S; Li M; Pei Y; Zhang S; Zou Y; Xu Y
Eur J Med Chem; 2023 Dec; 261():115846. PubMed ID: 37862816
[TBL] [Abstract][Full Text] [Related]
7. Mechanistic and evolutionary insights into isoform-specific 'supercharging' in DCLK family kinases.
Venkat A; Watterson G; Byrne DP; O'Boyle B; Shrestha S; Gravel N; Fairweather EE; Daly LA; Bunn C; Yeung W; Aggarwal I; Katiyar S; Eyers CE; Eyers PA; Kannan N
Elife; 2023 Oct; 12():. PubMed ID: 37883155
[TBL] [Abstract][Full Text] [Related]
8. FOXD3 Regulates CSC Marker, DCLK1-S, and Invasive Potential: Prognostic Implications in Colon Cancer.
Sarkar S; O'Connell MR; Okugawa Y; Lee BS; Toiyama Y; Kusunoki M; Daboval RD; Goel A; Singh P
Mol Cancer Res; 2017 Dec; 15(12):1678-1691. PubMed ID: 28851816
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of cytotoxic effects of gemcitabine by Dclk1 inhibition through suppression of Chk1 phosphorylation in human pancreatic cancer cells.
Kawamura D; Takemoto Y; Nishimoto A; Ueno K; Hosoyama T; Shirasawa B; Tanaka T; Kugimiya N; Harada E; Hamano K
Oncol Rep; 2017 Nov; 38(5):3238-3244. PubMed ID: 29048622
[TBL] [Abstract][Full Text] [Related]
10. Doublecortin and CaM kinase-like-1 as an independent prognostic factor in patients with resected pancreatic carcinoma.
Nishio K; Kimura K; Amano R; Nakata B; Yamazoe S; Ohira G; Miura K; Kametani N; Tanaka H; Muguruma K; Hirakawa K; Ohira M
World J Gastroenterol; 2017 Aug; 23(31):5764-5772. PubMed ID: 28883702
[TBL] [Abstract][Full Text] [Related]
11. Distinct Roles of HES1 in Normal Stem Cells and Tumor Stem-like Cells of the Intestine.
Goto N; Ueo T; Fukuda A; Kawada K; Sakai Y; Miyoshi H; Taketo MM; Chiba T; Seno H
Cancer Res; 2017 Jul; 77(13):3442-3454. PubMed ID: 28536281
[TBL] [Abstract][Full Text] [Related]
12. Dclk1-expressing tuft cells: critical modulators of the intestinal niche?
Middelhoff M; Westphalen CB; Hayakawa Y; Yan KS; Gershon MD; Wang TC; Quante M
Am J Physiol Gastrointest Liver Physiol; 2017 Oct; 313(4):G285-G299. PubMed ID: 28684459
[No Abstract] [Full Text] [Related]
13. Discovery of a selective inhibitor of doublecortin like kinase 1.
Ferguson FM; Nabet B; Raghavan S; Liu Y; Leggett AL; Kuljanin M; Kalekar RL; Yang A; He S; Wang J; Ng RWS; Sulahian R; Li L; Poulin EJ; Huang L; Koren J; Dieguez-Martinez N; Espinosa S; Zeng Z; Corona CR; Vasta JD; Ohi R; Sim T; Kim ND; Harshbarger W; Lizcano JM; Robers MB; Muthaswamy S; Lin CY; Look AT; Haigis KM; Mancias JD; Wolpin BM; Aguirre AJ; Hahn WC; Westover KD; Gray NS
Nat Chem Biol; 2020 Jun; 16(6):635-643. PubMed ID: 32251410
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of LEF1-Mediated DCLK1 by Niclosamide Attenuates Colorectal Cancer Stemness.
Park SY; Kim JY; Choi JH; Kim JH; Lee CJ; Singh P; Sarkar S; Baek JH; Nam JS
Clin Cancer Res; 2019 Feb; 25(4):1415-1429. PubMed ID: 30446587
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic Landscape and Therapeutic Implication of Gene Isoforms of Doublecortin-Like Kinase 1 for Cancer Stem Cells.
Moore LL; Houchen CW
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003596
[TBL] [Abstract][Full Text] [Related]
16. Expression of Stem Cell Markers in High-LET Space Radiation-Induced Intestinal Tumors in
Kwiatkowski E; Suman S; Kallakury BVS; Datta K; Fornace AJ; Kumar S
Cancers (Basel); 2023 Aug; 15(17):. PubMed ID: 37686516
[TBL] [Abstract][Full Text] [Related]
17. Structure-Guided Prediction of the Functional Impact of DCLK1 Mutations on Tumorigenesis.
Carli ALE; Hardy JM; Hoblos H; Ernst M; Lucet IS; Buchert M
Biomedicines; 2023 Mar; 11(3):. PubMed ID: 36979969
[TBL] [Abstract][Full Text] [Related]
18. Pleiotropic effects of DCLK1 in cancer and cancer stem cells.
Chhetri D; Vengadassalapathy S; Venkadassalapathy S; Balachandran V; Umapathy VR; Veeraraghavan VP; Jayaraman S; Patil S; Iyaswamy A; Palaniyandi K; Gnanasampanthapandian D
Front Mol Biosci; 2022; 9():965730. PubMed ID: 36250024
[TBL] [Abstract][Full Text] [Related]
19. DCLK1 promotes colorectal cancer stemness and aggressiveness via the XRCC5/COX2 axis.
Kim JH; Park SY; Jeon SE; Choi JH; Lee CJ; Jang TY; Yun HJ; Lee Y; Kim P; Cho SH; Lee JS; Nam JS
Theranostics; 2022; 12(12):5258-5271. PubMed ID: 35910805
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
